Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
109.50    2.00 (1.86%)
Bid:
105.50
Ask:
106.50
Spread: 1.00 (0.948%)
Market Cap: £107.91m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Trading Statement

21 Jan 2016 07:00

RNS Number : 4306M
Eurocell plc
21 January 2016
 

21 January 2016

Eurocell plc

Trading Update

 

Eurocell plc ("Eurocell" or the "Company"), the leading B2B, single brand supplier of PVC building products with its own distribution network announces a trading update for the 26 weeks ended 31st December 2015, in advance of its preliminary results announcement scheduled for Wednesday 16th March 2016.

The Company has continued to trade well with revenue for the second half expected to be £93.2 million, an increase of 3.6% on the previous year (H2 2014: £90.0 million), with revenues for the full year of £175.8 million, an increase of 1.6% (FY 2014: £173.1 million).

Despite the widely reported challenges in the UK RMI market, Eurocell showed positive revenue growth in its branch network of 3.9% v the same period in 2014. The Company continues to drive its branch expansion strategy with a further 13 additional Branches opened in 2015, taking the total to 141 at year end. To continue to support the future growth of the branch network, the company has invested further in improved support services during 2015, including a new management layer, increased technical sales staff and relief managers.

In addition to this the Company continues to improve gross margin through improvement in operating efficiencies and the further use of post-consumer recycling.

The Company expects profits to be within market expectations for the full year, with net debt of £26m at 31st December 2015.

 

Patrick Bateman, Chief Executive Officer, said "I am pleased with the outcome for the year, in which we have continued to grow revenue and profitability. The company will continue expanding its profitable branch network while bringing new products and materials to market. In addition the ongoing investment in our recycling operations to maintain our class leading gross margins and sustainable service to clients remains central to our strategy. Looking forward to this year, this strategy will be supported by ongoing bolt on acquisitions where the board feels such initiatives will further enhance Eurocell's integrated approach" 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEANFEALPKEEF
Date   Source Headline
21st Jul 20163:12 pmRNSHolding(s) in Company
30th Jun 20167:00 amRNSAwards to Directors and PDMRs
19th May 20162:43 pmRNSResult of AGM
19th May 20167:00 amRNSAGM Trading Update
21st Apr 20166:04 pmRNSHolding(s) in Company
20th Apr 20167:00 amRNSResult of Placing
19th Apr 20164:36 pmRNSProposed Placing
7th Apr 20163:58 pmRNSConfirmation of CEO Board Change
16th Mar 20167:00 amRNS2015 Full Year Results
9th Mar 20167:00 amRNSAcquisition
26th Jan 20167:04 amRNSDirectorate Change
21st Jan 20167:00 amRNSTrading Statement
1st Dec 20153:06 pmRNSHolding(s) in Company
11th Nov 201510:56 amRNSDirector Declaration
18th Sep 20159:56 amRNSHolding(s) in Company
17th Sep 201511:31 amRNSHolding(s) in Company
17th Sep 201511:29 amRNSHolding(s) in Company
15th Sep 201511:06 amRNSResult of Placing
15th Sep 20157:00 amRNSProposed Placing
25th Aug 20157:00 amRNSHalf Yearly Results
29th May 20152:59 pmRNSChange of Adviser
13th May 20155:32 pmRNSHolding(s) in Company
14th Apr 20157:00 amRNSAppointment of Joint Corporate Brokers
11th Mar 20154:33 pmRNSHolding(s) in Company
11th Mar 20153:17 pmRNSHolding(s) in Company
10th Mar 20157:03 amRNSAnnouncement of Grant Awards
9th Mar 20158:00 amRNSAdmission to Trading on London Stock Exchange
4th Mar 20152:31 pmRNSPublication of Prospectus
4th Mar 20157:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.